Press Releases and Publications
New ALS Therapies Move Closer to the Clinic
UAMS Scientists Create Promising Mouse Model
UAMS Scientists Create Promising Mouse Model
After two decades of failure, novel scientific insights and technical progress are spurring meaningful innovation in the field.
UAMS Scientists Create Promising Mouse Model
UAMS Scientists Create Promising Mouse Model
UAMS Scientists Create Promising Mouse Model
Dr. Kiaei's laboratory developed a new mouse model of neurodegenerative disease.
Mice Recapitulate Cardinal Features
Mice Recapitulate Cardinal Features
Mice Recapitulate Cardinal Features
To investigate the pathological role of mutant profilin1 in motor neuron disease, we generated transgenic lines of mice expressing human profilin1 with a mutation at position 118 (hPFN1 G118V ).
Story by AlzForum
Mice Recapitulate Cardinal Features
Mice Recapitulate Cardinal Features
Alzforum.org reports on the research of Dr. Kiaei, president and CEO of RockGen Therapeutics.
Conferences
35th International Symposium on ALS/MND
35th International Symposium on ALS/MND
35th International Symposium on ALS/MND
The International Symposium is the biggest annual conference dedicated to ALS and MND research. Each year we bring together researchers from around the world to share a new understanding of amyotrophic lateral sclerosis and motor neurone disease.
Neuroscience 2024
35th International Symposium on ALS/MND
35th International Symposium on ALS/MND
The Society for Neuroscience (SfN) has opened submissions for the Trainee Professional Development Award (TPDA), running from May 14, 2024, 8:00 AM ET to May 28, 2024, 5:00 PM ET.
Resources for Patients